New insights into cardiac defects in Myotonic Dystrophy Type 1

People with Myotonic Dystrophy Type 1 (DM1), the most common adult-onset form of muscular dystrophy, progressively lose muscle mass and strength in their lower legs, hands, neck and face.

Anivive secures funds for human Valley Fever vaccine development

The company plans to conduct a Phase I clinical trial of the vaccine in humans. Credit: Billion Photos / Shutterstock. Anivive Lifesciences, a One Health

August 5, 2024

Vidac secures funding to advance skin cancer trials of novel ointment – Pharmaceutical Technology

Actinic keratosis is a pre-cancerous area of thick, scaly, or crusty skin. Credit: Douglas Cliff via Shutterstock. Vidac Pharma has secured €600,000 ($645,651) in additional

November 7, 2024

Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments

A new company founded by a group of biotech veterans, including Bob Langer, came out of stealth mode Tuesday with plans to create pills for

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.